Zacks Small Cap Research - ONCS: New Data Provide Evidence that ImmunoPulse IL-12 Can Prime the Immune System
Combination chemotherapy with paclitaxel, cisplatin and fluorouracil for patients with advanced and metastatic gastric or esophagogastric junction adenocarcinoma: a multicenter prospective study - Chinese Journal of Cancer Research
Best overall response (per RECIST 1.1, based on investigator assessment) | Download Scientific Diagram
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study | SpringerLink
Best Overall Response Rate (full analysis population) | Download Table
DS08: Deconstructing ADRS: Tumor Response Analysis Data Set
Best Overall Response Rate to Treatment | Download Table
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma | NEJM
Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1) | British Journal of Cancer
Efficacy endpoints in Oncology
Best overall tumor response and objective response rate | Download Table
Efficacy I PLUVICTO
Overall Response Rate of 76% in Advanced Melanoma Patients
Best overall response rate and clinical benefit rate for patients with... | Download Scientific Diagram
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study | Journal of Clinical Oncology
Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study | SpringerLink
Durable Response Rate
Best Overall Response per irRC by Investigator Assessment | Download Table
Best Overall Response per Response Evaluation Criteria in Solid | Download Scientific Diagram
EPOCH trial - Boston Scientific
Overall response rate | Download Table
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Disease Response Swimmer Plot
Durable Responses Are Observed With Cemiplimab in mBCC
